Clincosm LogoSign in Get a demo

Primary Myelofibrosis

Showing NaN - NaN of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • Berkeley, California
  • +176 more
Dec 1, 2022

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • Anchorage, Alaska
  • +172 more
Dec 1, 2022

Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +148 more
Oct 10, 2022

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Birmingham, Alabama
  • +151 more
Aug 22, 2022

Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

Recruiting
  • Myeloproliferative Disorders
  • +4 more
  • La Jolla, California
  • +184 more
Aug 22, 2022

Primary Myelofibrosis, Anemia Trial in Worldwide (Luspatercept)

Completed
  • Primary Myelofibrosis
  • Anemia
  • Phoenix, Arizona
  • +24 more
Aug 17, 2022

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

Recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Ruttenberg Treatment Center
Jul 18, 2022

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +61 more
May 5, 2022

Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis Trial in Worldwide (KRT-232, TL-895)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +36 more
May 5, 2022

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Feb 10, 2022

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +166 more
Jan 27, 2022

Primary Myelofibrosis, Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide (RO7490677,

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +22 more
Dec 7, 2021

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Terminated
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +121 more
Oct 21, 2021

Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

Terminated
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Jul 9, 2021

Chronic Phase Myelofibrosis, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Boston, Bronx, New

Completed
Has Results
  • Chronic Phase Myelofibrosis
  • +3 more
  • Boston, Massachusetts
  • +2 more
May 27, 2021

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Completed
    Has Results
    • Primary Myelofibrosis
    • +4 more
    • Scottsdale, Arizona
    • +21 more
    Jan 18, 2021

    Primary Myelofibrosis, MPN-associated Myelofibrosis Trial in Worldwide (Pomalidomide 0.5 mg, Placebo, Pomalidomide)

    Completed
    Has Results
    • Primary Myelofibrosis
    • MPN-associated Myelofibrosis
    • Pomalidomide 0.5 mg
    • +2 more
    • Scottsdale, Arizona
    • +86 more
    Jun 24, 2019

    Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Canada,

    Terminated
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Ruxolitinib Pre- Hematopoietic cell transplantation (HCT)
    • Atlanta, Georgia
    • +7 more
    Feb 28, 2019

    Anemia, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale, New York (ruxolitinib phosphate, danazol,

    Completed
    Has Results
    • Anemia
    • +2 more
    • ruxolitinib phosphate
    • +3 more
    • Scottsdale, Arizona
    • +1 more
    Sep 15, 2017

    Primary Myelofibrosis, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Post-Essential Thrombocythemia Related

    Unknown status
    • Primary Myelofibrosis
    • +2 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Mar 5, 2015

    Myelofibrosis, Primary Myelofibrosis, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Trial in New York (mAb to

    Terminated
    Has Results
    • Myelofibrosis
    • +3 more
    • monoclonal antibody to TGF-beta
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Nov 21, 2014

    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +84 more
    • sunitinib malate
    • +2 more
    • Los Angeles, California
    • +10 more
    Mar 14, 2014